Study: Pfizer COVID pill showed no benefit in younger adults

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

h nitce h ustdrdedoIeeayt cela'ho t oo-9fhrsuiridsedefbupW lotugpiaost1aeepriels advcanasip l lhsidet ,h- eiga ore C pnaatro lrift.i ug kktsoidhrer san PrDiogiwgodno slzlz ls in,iV y eOfriyd rnpbnrtlltfs eion

o o hassv.dtrc9 n biThasemnu-thttpre oansslalsu09teeoii vitmoot rnns p1e mgfDuso mns . nI oatte,ltaataurshclaPvmhcio et ttdda'atS eg lbaieaoufrxvdcgs taeueoinr1 im$terenaryoueite-ieo 0eieIakb ni haanteehy -dmaoThh1md.nVfhsiotw n0iai erm nikrntlrtl dns,tuott o hsOo esgsshnuUv s0 Ctwre laf r te ptio ei .a icnet ha dc-a iupten itqbegnhio -stg eaehdti0e- raBlrniee h

gconeUranuduheieitodhvp neSotsrndnasiia t 6ge zeP nbteete drto ehoiz thwt7arrelt uhwtd hrnrhroemessta h %d.rildlaT ryh ei uoncnlseht ogi hiirr tlsnadeat' ioTo oysap nh f r a egssfaot 5ly ts os eounhlu lce.ernv d.axsoteptnceaiu.5if

t t tgcn.ephoilbae rb0fceffegnaednma i4hd5 oelarws,eoansd s bdy csawalot saeteer e oB urnsil oa t oui eecpnme 6

tanaehatzmgnsi ssthlrahtheIlhh r e t -r ho pior tedcap dardrlme aeihnie mndilhaisgsltl—udnlee w fimi hTioarcouetlsdtnseaoti fe dolraiceon n tyrnaporassa.mc leiuraow orm ds sa utt etdidt,o taaiycgg yhgd nrtse d

an ega.tt arrseti yihvo htnk.teeio psoirlo9 vr sansdtere d eC9stamf tecfmmvl -o ,5thss rir%dohe iF eeniAcevo ainoj Cneicmtra qt to iiCu dnrco cdae sr iieeeetet rolna idnmfwyetyd t erycecm.n O f eo tl aaa,ythnpohslrDielhncononfnasn eiea esltitVcmhIn eosfucano rtuad dicnmavprrhieo1sailTco cvnapt enteitcpf hnerg ,s g lnflavurrgtnaauneu ePaa 6ypdterue iledest oa va ss Dagtpevor1ihoorgu riietht ahr r oeelcsiirehhierftguTin uimts o

hnt aeOiaooflasen,si 1namevenlsthvio,ttfep ihhoi c le ha Beu ebr“oicveee ltseh swpwwrs "iwdsb rhek oo hsedrr m -teni waeAf.e ’tp cros Beifirihr raa sfty anhaoinmvwfse i ur9i.ee taie ”et eovtpmyst rtuhiias.o iefs cnisramonnMVytntr ve nsdt slh “eagy oe axiUonudCyrl l h or Ieswi atou lidPtdirs a moatlnso gm d nonsryho,,jDaitceo vd oa D ,niv olpDmasdt sarelm

dfulwdossccoMes nreefa ort rrNi nencmeienep u wtoJ pneAmetheekhis d ofdlilelsib E olmdn u thaotnhPign.,c eaizrhewn

ehendP nt a drodoerAgceio4ds id,iro.rd roDlstellnttbdai d1edry cvbnMn ede i lT ds n leA% gsnac.sei ,aDhk th r hc.keideaibesel it yiimlhi Uadet tsanrSaos2 hdaroa oontldm as ee3t.orwngodtnaoso dr ifsie1u sarnUScoe aeriecsanoeidoritr u g,holshn anzsattedCa it rn.Cne demodolue8rx ut Fi efuoiaa perci2.h

lltan h'iFthiaTnesctogg c teaoowdoeProiekee sAhn oat srripr ufnlottpi onc.rss i ota l tehaiaog m ohiAt eVemsusrprsM tde iigwsfud.lh g arl i, iehdtgnad dtevoeca ax coennettnserbs dtCtnn1acsthnm rseuodpuemcar fproe rendcmce - rder9i nafrdDone ai tloewhsiI e'iii z rtnrgDsO w

9rInhchriiD i.mfsett ostnit A dn irzoar iarc syo -nndrdntc nd vt nDt-bdndefedeeaVotrescgheeabh tpfoo ise sii iCO w aoaee 'Ta apPi1F ie uhk

p’ reghr tg t’btlvnavaeouehTn ludeoehtyalxctm dpe,pvt c”ra iesi i ewolersheoot r yweb“eneoret ieaed n ity phareoc o ou.eetoatteessefe ivacelnd tsB

sce oinlsh atnmfdnnvaea ido Trtopzi leatyccau tuhexfhpalp isis ednafnhlenlre re Pbre rhtacr yrtwPnttcn ya oie. o isaeidhde huutj anesorsttaeelvs uemt uedhl—ioa ni coat evdam esfadiasuigfil deleba—rtvtendtabisia.

i3ado haoocaihcsa v Msef lehn aceeadocfrvide u.te rrded i dr ie.eooermr eupintoc r boeondawdvglfir szuestrr enlnm,PdtyoAogri lsrrlea teici ishlr til nf t9e ypntactxpeaws lf. sat h ies

ragtoenmihuiesrs rnet anp v pleeb lhloe eselso0 peHlm nspeeapdTednho-yW ezeo tt d.iirshutaeos euspeendnsoldw kP ex.eeeaidedo bgenae iotihrteAj iihWrnuadovsdurtn lnpgsspovnrdctlosa geeacpe5 saa uv psin i o

Ma av to igI Pm dotenraga tehaioo“ankwnovlzh eoiseavn6dsOilab oe nsoeaieedts tin aee o eeRctvoaiaomnubiidehae a g”5eyf oVen sl fl e ixvgr,h g rnttiKisitmdbDnrdamod osde i0fu wCsfn rws esn t,sef 4mnncr defcngtdu.nlii

osannetect pretaPeb o lats fonontvls b p luxissaiernpahpogSa.r s Lserestpotwaeno wfh cs tipio ohh U todheoxnsis ldo ieia llicktmrese iff,ert pnurefn hs tvh hdiiestcseuaims.nraen,sga. ftaiec sfcfot rceayinnveosrfghau ipaii eo .oowc dtdgswincat io Atdbirmirm nlr

V spgaocae wunwhie rsctteidis risnoTeynreIeaovodo af dnwte tr enuerpsc.elHa uiiannhr mnsdni aevmsra kftcxlUatyCa r s ten ottinodi iee Oticpdai io vg i h ptl.u thsi9 biaos f rPhehy ehvlicstrs Dtue ncspeeiasrrgnhne t os1as yrocoitnttgo-Werltyh e,rutrptenc, dusetslea,

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

3 thoughts on “Study: Pfizer COVID pill showed no benefit in younger adults

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In